Literature DB >> 4170060

New antigens in human leukaemic cells and antibody in the serum of leukaemic patients.

J F Dore, R Motta, L Marholev, I Hrsak, H Colas de la Noue, G Seman, F De Vassal, G Mathé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4170060     DOI: 10.1016/s0140-6736(67)93027-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Immunological studies in acute leukemia.

Authors:  G W Santos; P N Anderson; D L Klein; W B Bias; B Z Schacter; G M Mullins; P J Burke
Journal:  Trans Am Clin Climatol Assoc       Date:  1977

Review 2.  Evaluation of current cancer immunotherapy: hemato-oncology.

Authors:  Christopher S Hourigan; Hyam I Levitsky
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

3.  Cytotoxicity against human leukaemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myeloblasts.

Authors:  P Hersey; I C MacLennan; A C Campbell; R Harris; C B Freeman
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

4.  Immunological treatment of leukaemias.

Authors:  G Mathé
Journal:  Br Med J       Date:  1970-11-21

5.  Lymphocytotoxins in leukaemia.

Authors:  A Dickson
Journal:  Br Med J       Date:  1972-10-28

6.  Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.

Authors:  D L Morton; F R Eilber; W L Joseph; W C Wood; E Trahan; A S Ketcham
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

7.  Transience of immune responses to tumour antigens in man.

Authors:  J L Odili; G Taylor
Journal:  Br Med J       Date:  1971-12-04

8.  Immune complexes and circulating antibodies against autologous leukaemic cells in patients with acute leukaemias.

Authors:  M Bertini; G Galetto; P M Comoglio
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

9.  Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.

Authors:  S Pullen; P Hersey
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

Review 10.  The immunological approach to cancer treatment.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider
Journal:  J R Coll Physicians Lond       Date:  1970-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.